Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseases
US10561707B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 24, 2017 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | Jan 24, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, according to some embodiments, method of treating eye diseases, such as AMD by administering Semaphorin 3C (Sema3C) or a variant thereof having amino acid modifications at furin-like pro-protein convertase cleavage sites, rendering these sites resistant to cleavage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.